Management of chronic Giardia infection

References

• WHO. The world health report 1996. Fighting disease fostering development. WHO; Geneva, Switzerland: 1996
   Google Scholar
• Escobedo AA, Almirall P, Robertson LJ, et al. Giardiasis: the ever-present threat of a neglected disease. Infect Disord Drug Targets 2010;10:329-48
   PubMedGoogle Scholar
• Halliez MC, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013;19:8974-85
   PubMed Web of Science ®Google Scholar
• Mørch K, Hanevik K, Rortveit G, et al. High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. Trans R Soc Trop Med Hyg 2009;103:530-2
   PubMed Web of Science ®Google Scholar
• Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009;9:27
   PubMed Web of Science ®Google Scholar
• Wensaas KA, Langeland N, Hanevik K, et al. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut 2012;61:214-19
   PubMed Web of Science ®Google Scholar
• Berkman DS, Lescano AG, Gilman RH, et al. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet 2002;359:564-71
   PubMed Web of Science ®Google Scholar
• Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative’. Trends Parasitol 2006;22:203-8
   PubMed Web of Science ®Google Scholar
• Thompson RC. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 2000;30:1259-67
   PubMed Web of Science ®Google Scholar
• Chester AC, MacMurray FG, Restifo MD, Mann O. Giardiasis as a chronic disease. Dig Dis Sci 1985;30:215-18
   PubMed Web of Science ®Google Scholar
• Rendtorff RC. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg 1954;59:209-20
   PubMed Web of Science ®Google Scholar
• Hunter PR, Thompson RC. The zoonotic transmission of Giardia and Cryptosporidium. Int J Parasitol 2005;35:1181-90
   PubMed Web of Science ®Google Scholar
• Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25
   PubMed Web of Science ®Google Scholar
• Yoder JS, Beach MJ. Giardiasis surveillance – United States, 2003-2005. MMWR Surveill Summ 2007;56:11-18
   PubMedGoogle Scholar
• Hörman A, Korpela H, Sutinen J, et al. Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries. Int J Parasitol 2004;34:1337-46
   PubMed Web of Science ®Google Scholar
• Snel SJ, Baker MG, Kamalesh V, et al. A tale of two parasites: the comparative epidemiology of cryptosporidiosis and giardiasis. Epidemiol Infect 2009;137:1641-50
   PubMed Web of Science ®Google Scholar
• Stuart JM, Orr HJ, Warburton FG, et al. Risk factors for sporadic giardiasis: a case-control study in southwestern England. Emerg Infect Dis 2003;9:229-33
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Almirall P, Alfonso M, et al. Sexual transmission of giardiasis: a neglected route of spread? Acta Trop 2014;132:106-11
   PubMed Web of Science ®Google Scholar
• Núñez FA, López JL, de la Cruz AM, Finlay CM. [Risk factors for Giardia lamblia infection in children in daycare centers in Havana, Cuba]. Cad Saude Publica 2003;19:677-82
   PubMedGoogle Scholar
• Abossie A, Seid M. Assessment of the prevalence of intestinal parasitosis and associated risk factors among primary school children in Chencha town, Southern Ethiopia. BMC Public Health 2014;14:166
   PubMed Web of Science ®Google Scholar
• Oksenhendler E, Gérard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008;46:1547-54
   PubMed Web of Science ®Google Scholar
• Domínguez-López ME, González-Molero I, Ramírez-Plaza CP, et al. Diarrea crónica refractaria y malabsorción secundaria a hipogammaglobulinemia común variable, infestación crónica por Giardia lamblia y gastrectomía total por adenocarcinoma gástrico: un manejo nutricional complejo. Nutr Hosp 2011;26:922-5
   PubMed Web of Science ®Google Scholar
• Webster AD. Giardiasis and immunodeficiency diseases. Trans R Soc Trop Med Hyg 1980;74:440-3
   PubMed Web of Science ®Google Scholar
• Noureldin MS, Shaltout AA, El Hamshary EM, Ali ME. Opportunistic intestinal protozoal infections in immunocompromised children. J Egypt Soc Parasitol 1999;29:951-61
   PubMedGoogle Scholar
• Roberts DM, Craft JC, Mather FJ, et al. Prevalence of giardiasis in patients with cystic fibrosis. J Pediatr 1988;112:555-9
   PubMed Web of Science ®Google Scholar
• Copelovitch L, Sam Ol O, Taraquinio S, Chanpheaktra N. Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites. J Pediatr 2010;156:76-81
   PubMed Web of Science ®Google Scholar
• Azami M, Sharifi M, Hejazi SH, Tazhibi M. Intestinal parasitic infections in renal transplant recipients. Braz J Infect Dis 2010;14:15-18
   PubMed Web of Science ®Google Scholar
• Laughon BE, Druckman DA, Vernon A, et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988;94:984-93
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Núñez FA. Prevalence of intestinal parasites in Cuban acquired immunodeficiency syndrome (AIDS) patients. Acta Trop 1999;72:125-30
   PubMed Web of Science ®Google Scholar
• Cimerman S, Cimerman B, Lewi DS. Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil. Int J Infect Dis 1999;3:203-6
   PubMedGoogle Scholar
• Kumkum Khanna R, Nain CK, et al. Depressed humoral immune responses to surface antigens of Giardia lamblia in persistent giardiasis. Pediatr Infect Dis J 1988;7:492-8
   PubMed Web of Science ®Google Scholar
• Newman RD, Moore SR, Lima AA, et al. A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Trop Med Int Health 2001;6:624-34
   PubMed Web of Science ®Google Scholar
• Núñez FA, Hernández M, Finlay CM. Longitudinal study of giardiasis in three day care centres of Havana City. Acta Trop 1999;73:237-42
   PubMed Web of Science ®Google Scholar
• Hagel I, Cabrera M, Puccio F, et al. Co-infection with Ascaris lumbricoides modulates protective immune responses against Giardia duodenalis in school Venezuelan rural children. Acta Trop 2011;117:189-95
   PubMed Web of Science ®Google Scholar
• Robertson LJ, Hanevik K, Escobedo AA, et al. Giardiasis – why do the symptoms sometimes never stop? Trends Parasitol 2010;26:75-82
   PubMed Web of Science ®Google Scholar
• Roxström-Lindquist K, Palm D, Reiner D, et al. Giardia immunity--an update. Trends Parasitol 2006;22:26-31
   PubMed Web of Science ®Google Scholar
• Banik S, Renner Viveros P, Seeber F, et al. Giardia duodenalis arginine deiminase modulates the phenotype and cytokine secretion of human dendritic cells by depletion of arginine and formation of ammonia. Infect Immun 2013;81:2309-17
   PubMed Web of Science ®Google Scholar
• Kamda JD, Nash TE, Singer SM. Giardia duodenalis: dendritic cell defects in IL-6 deficient mice contribute to susceptibility to intestinal infection. Exp Parasitol 2012;130:288-91
   PubMed Web of Science ®Google Scholar
• Nash TE, Herrington DA, Losonsky GA, Levine MM. Experimental human infections with Giardia lamblia. J Infect Dis 1987;156:974-84
   PubMed Web of Science ®Google Scholar
• Hanevik K, Hausken T, Morken MH, et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect 2007;55:524-30
   PubMed Web of Science ®Google Scholar
• Arévalo F, Aragón V, Morales LD, et al. [Duodenal villous atrophy, an unexpectedly common finding in Giardia lamblia infestation]. Rev Gastroenterol Peru 2010;30:272-6
   PubMedGoogle Scholar
• Oberhuber G, Stolte M. Giardiasis: analysis of histological changes in biopsy specimens of 80 patients. J Clin Pathol 1990;43:641-3
   PubMed Web of Science ®Google Scholar
• Koot BG, ten Kate FJ, Juffrie M, et al. Does Giardia lamblia cause villous atrophy in children? : a retrospective cohort study of the histological abnormalities in giardiasis. J Pediatr Gastroenterol Nutr 2009;49:304-8
   PubMed Web of Science ®Google Scholar
• Cotton JA, Beatty JK, Buret AG. Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol 2011;41:925-33
   PubMed Web of Science ®Google Scholar
• Farthing MJ. Giardiasis. Gastroenterol Clin North Am 1996;25:493-515
   PubMed Web of Science ®Google Scholar
• Troeger H, Epple HJ, Schneider T, et al. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut 2007;56:328-35
   PubMed Web of Science ®Google Scholar
• Koh WH, Geurden T, Paget T, et al. Giardia duodenalis assemblage-specific induction of apoptosis and tight junction disruption in human intestinal epithelial cells: effects of mixed infections. J Parasitol 2013;99:353-8
   PubMed Web of Science ®Google Scholar
• Ankarklev J, Hestvik E, Lebbad M, et al. Common coinfections of Giardia intestinalis and Helicobacter pylori in non-symptomatic Ugandan children. PLoS Negl Trop Dis 2012;6:e1780
   PubMed Web of Science ®Google Scholar
• Koehler AV, Jex AR, Haydon SR, et al. Giardia/giardiasis - a perspective on diagnostic and analytical tools. Biotechnol Adv 2014;32(2):280-9
   PubMed Web of Science ®Google Scholar
• Kenny JM, Kelly P. Protozoal gastrointestinal infections. Medicine 2009;37:599-602
   Google Scholar
• Goka AK, Rolston DD, Mathan VI, Farthing MJ. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg 1990;84:66-7
   PubMed Web of Science ®Google Scholar
• Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa? Am J Trop Med Hyg 1995;53:36-9
   PubMed Web of Science ®Google Scholar
• Kamath KR, Murugasu R. A comparative study of four methods for detecting Giardia lamblia in children with diarrheal disease and malabsorption. Gastroenterology 1974;66:16-21
   PubMed Web of Science ®Google Scholar
• Rosenthal P, Liebman WM. Comparative study of stool examinations, duodenal aspiration, and pediatric enterotest for giardiasis in children. J Pediatr 1980;96:278-9
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Kastner N, Stolte M. Giardiasis: a histologic analysis of 567 cases. Scand J Gastroenterol 1997;32:48-51
   PubMed Web of Science ®Google Scholar
• Wahnschaffe U, Ignatius R, Loddenkemper C, et al. Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas. Scand J Gastroenterol 2007;42:391-6
   PubMed Web of Science ®Google Scholar
• Garcia LS. Diagnostic medical parasitology: an update. Clin Microbiol Newsl 1994;16:105-10
   Google Scholar
• Mank TG, Zaat JO, Deelder AM, et al. Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis. Eur J Clin Microbiol Infect Dis 1997;16:615-19
   PubMed Web of Science ®Google Scholar
• Strand EA, Robertson LJ, Hanevik K, et al. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clin Microbiol Infect 2008;14:1069-71
   PubMed Web of Science ®Google Scholar
• Garcia LS, Shimizu RY, Bernard CN. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the Triage parasite panel enzyme immunoassay. J Clin Microbiol 2000;38:3337-40
   PubMed Web of Science ®Google Scholar
• Garcia LS, Shimizu RY, Novak S, et al. Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J Clin Microbiol 2003;41:209-12
   PubMed Web of Science ®Google Scholar
• Weitzel T, Dittrich S, Möhl I, et al. Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clin Microbiol Infect 2006;12:656-9
   PubMed Web of Science ®Google Scholar
• Ghosh S, Debnath A, Sil A, et al. PCR detection of Giardia lamblia in stool: targeting intergenic spacer region of multicopy rRNA gene. Mol Cell Probes 2000;14:181-9
   PubMed Web of Science ®Google Scholar
• Guy RA, Xiao C, Horgen PA. Real-time PCR assay for detection and genotype differentiation of Giardia lamblia in stool specimens. J Clin Microbiol 2004;42:3317-20
   PubMed Web of Science ®Google Scholar
• Verweij JJ, Schinkel J, Laeijendecker D, et al. Real-time PCR for the detection of Giardia lamblia. Mol Cell Probes 2003;17:223-5
   PubMed Web of Science ®Google Scholar
• Adam CFL, Dear PH, Pedraza-Díaz S, et al. McLauchlin. Sensitive PCR-restriction fragment length polymorphism assay for detection and genotyping of Giardia duodenalis in human feces. J Clin Microbiol 2002;40:446-52
   PubMed Web of Science ®Google Scholar
• Cacciò SM, Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol 2008;160:75-80
   PubMed Web of Science ®Google Scholar
• Duncombe VM, Bolin TD, Davis AE, et al. Histopathology in giardiasis: a correlation with diarrhoea. Aust N Z J Med 1978;8:392-6
   PubMedGoogle Scholar
• McIntyre P, Boreham PF, Phillips RE, Shepherd RW. Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture. J Pediatr 1986;108:1005-10
   PubMed Web of Science ®Google Scholar
• Buret A.G. Pathophysiology of enteric infections with Giardia duodenalis. Parasite 2008;15:261-5
   PubMed Web of Science ®Google Scholar
• Solaymani-Mohammadi S, Singer SM. Host immunity and pathogen strain contribute to intestinal disaccharidase impairment following gut infection. J Immunol 2011;187:3769-75
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76
   PubMed Web of Science ®Google Scholar
• Mahnel R, Marth T. Progress, problems, and perspectives in diagnosis and treatment of Whipple’s disease. Clin Exp Med 2004;4:39-43
   PubMed Web of Science ®Google Scholar
• Brown WR, Tayal S. Microscopic colitis. A review. J Dig Dis 2013;14:277-81
   PubMed Web of Science ®Google Scholar
• Storr MA. Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. ISRN Gastroenterol 2013;2013:352718
   PubMedGoogle Scholar
• Münch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012;6:932-45
   PubMed Web of Science ®Google Scholar
• Mearin F. Postinfectious functional gastrointestinal disorders. J Clin Gastroenterol 2011;45(Suppl):S102-5
   PubMed Web of Science ®Google Scholar
• Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009;9:27
   PubMed Web of Science ®Google Scholar
• Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979-88
   PubMed Web of Science ®Google Scholar
• Hanevik K, Mørch K, Eide GE, et al. Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial. Scand J Infect Dis 2008;40:517-22
   PubMed Web of Science ®Google Scholar
• Gilman RH, Marquis GS, Miranda E, et al. Rapid re-infection by Giardia lamblia after treatment in a hyperendemic Third World community. Lancet 1988;1:343-5
   PubMed Web of Science ®Google Scholar
• Sullivan PS, DuPont HL, Arafat RR, et al. Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: the case against treatment in developing world environments of high endemicity. Am J Epidemiol 1989;127:1272-81
   Web of Science ®Google Scholar
• Saffar MJ, Qaffari J, Khalilian AR, Kosarian M. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic area: the case against treatment. East Mediterr Health J 2005;11:73-8
   PubMedGoogle Scholar
• Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother 2007;8:1885-902
   PubMed Web of Science ®Google Scholar
• Muhsen K, Levine MM. A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries. Clin Infect Dis 2012;55(Suppl 4):S271-93
   PubMed Web of Science ®Google Scholar
• Cantey PT, Roy S, Lee B, et al. Study of nonoutbreak giardiasis: novel findings and implications for research. Am J Med 2011;124:1175 e1-8
   PubMed Web of Science ®Google Scholar
• Kampitak T. Selective immunoglobulin M deficiency in a patient with refractory giardiasis. J Investig Allergol Clin Immunol 2010;20:358-60
   PubMed Web of Science ®Google Scholar
• Gardner TB, Hill DR. Treatment of giardiasis. Clin Microb Rev 2001;14:114-28
   PubMed Web of Science ®Google Scholar
• Harris JC, Plummer S, Lloyd D. Antigiardial drugs. Appl Microbiol Biotechnol 2001;57:614-19
   PubMed Web of Science ®Google Scholar
• Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf 2003;2:529-41
   PubMedGoogle Scholar
• Kiser JD, Paulson CP, Brown C. Clinical inquiries. What’s the most effective treatment for giardiasis? J Fam Pract 2008;57:270-2
   PubMed Web of Science ®Google Scholar
• Chandy E, McCarthy J. Evidence behind the WHO guidelines: hospital care for children: What is the most appropriate treatment for giardiasis? J Trop Pediatr 2009;55:5-7
   PubMed Web of Science ®Google Scholar
• Busatti HG, Santos JF, Gomes MA. The old and new therapeutic approaches to the treatment of giardiasis: where are we? Biologics 2009;3:273-87
   PubMedGoogle Scholar
• Tian HF, Chen B, Wen JF. Giardiasis, drug resistance, and new target discovery. Infect Disord Drug Targets 2010;10:295-302
   PubMedGoogle Scholar
• Lalle M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets 2010;10:283-94
   PubMedGoogle Scholar
• Tejman-Yarden N, Eckmann L. New approaches to the treatment of giardiasis. Curr Opin Infect Dis 2011;24:451-6
   PubMed Web of Science ®Google Scholar
• Pasupuleti V, Escobedo AA, Deshpande A, et al. Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials. PLoS Negl Trop Dis 2014;8:e2733
   PubMed Web of Science ®Google Scholar
• Zaat JO, Mank TG, Assendelft WJ. A systematic review on the treatment of giardiasis. Trop Med Int Health 1997;2:63-82
   PubMed Web of Science ®Google Scholar
• Fung HB, Doan TL. Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther 2005;27:1859-84
   PubMed Web of Science ®Google Scholar
• Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 1996;51:621-38
   PubMed Web of Science ®Google Scholar
• Mørch K, Hanevik K, Robertson LJ, et al. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 2008;56:268-73
   PubMed Web of Science ®Google Scholar
• Davidson RN, den Boer M, Ritmeijer K. Paromomycin. Trans R Soc Trop Med Hyg 2009;103:653-60
   PubMed Web of Science ®Google Scholar
• Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis 2010;4:e682
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Cimerman S, Almirall P. An old drug against giardiasis: mebendazole as a treatment option. Infect Disord Drug Targets 2011;11:94-5
   PubMedGoogle Scholar
• Romero Cabello R, Guerrero LR, Munoz Garcia MR, Geyne Cruz A. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 1997;91:701-3
   PubMed Web of Science ®Google Scholar
• Abaza H, El-Zayadi A, Kabil SM, Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr Ther Res 1998;59:116-21
   Web of Science ®Google Scholar
• Rodriguez-Garcia R, Rodriguez-Guzman LM, Cruz del Castillo AH. Eficacia y seguridad de mebendazole contra nitazoxanida en el tratamiento de Giardia lamblia en niños. Rev Gastroenterol Mex 1999;64:122-6
   PubMedGoogle Scholar
• Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:381-4
   PubMed Web of Science ®Google Scholar
• Ortiz JJ, Ayoub A, Gargala G, et al. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther 2001;15:1409-15
   PubMed Web of Science ®Google Scholar
• Adagu SI, Nolder D, Warhurst DC, Rossignol JF. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother 2002;49:103-11
   PubMed Web of Science ®Google Scholar
• Davila-Gutierrez CE, Vazquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg 2002;66:251-4
   PubMed Web of Science ®Google Scholar
• Díaz E, Mondragón J, Ramirez E, Bernal R. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003;68:384-5
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Álvarez G, González ME, et al. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol 2008;102:199-207
   PubMed Web of Science ®Google Scholar
• Gazder AJ, Banerjee M. Single dose therapy of giardiasis with tinidazole and metronidazole. Drugs 1978;15(Suppl 1):30-2
   PubMed Web of Science ®Google Scholar
• van den Bijllaardt W, Overdevest IT, Buiting AG, Verweij JJ. Rapid clearance of Giardia lamblia DNA from the gut after successful treatment. Clin Microbiol Infect 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Jokipii AMM, Jokipii L. The prepatency of Giardia. Lancet I 1977;1(8021):1095-7
   PubMed Web of Science ®Google Scholar
• Nash TE, Ohl CA, Thomas E, et al. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001;33:22-8
   PubMed Web of Science ®Google Scholar
• Lima J, Nazarian L, Charney E, Lahti C. Compliance with short-term antimicrobial therapy: some techniques that help. Pediatrics 1976;57:383-6
   PubMed Web of Science ®Google Scholar
• Kampitak T. Selective immunoglobulin M deficiency in a patient with refractory giardiasis. J Investig Allergol Clin Immunol 2010;20:358-60
   PubMed Web of Science ®Google Scholar
• Lo Line Mei C, Sankale M, Pene P. Les giardiasis rebelles. Médecine d´Afrique Noire 1987;34:1063-8
   Google Scholar
• Taylor GD, Wenman WM, Tyrrell DL. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. CMAJ 1987;136:1179-80
   PubMed Web of Science ®Google Scholar
• Al Karawi M, Salam I, Mohamed AE. Combined oral and endoscopic mepacrine therapy in a case of persistent chronic symptomatic giardiasis. Trans R Soc Trop Med Hyg 1988;82:581
   PubMed Web of Science ®Google Scholar
• Rowedder A, Meier R, Wegmann W, Gyr K. [Combined oral and endoscopic mepacrine therapy in therapy-resistant symptomatic giardiasis]. Schweiz Med Wochenschr 1991;121:1383-6
   PubMedGoogle Scholar
• Elliott AM, Klaus BD, North DS, Martin HP. Furazolidone-induced mood disorder during the treatment of refractory giardiasis in a patient with AIDS. Clin Infect Dis 1998;26:1015
   PubMed Web of Science ®Google Scholar
• Abboud P, Lemée V, Gargala G, et al. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2001;32:1792-4
   PubMed Web of Science ®Google Scholar
• Tejman-Yarden N, Miyamoto Y, Leitsch D, et al. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother 2013;57:2029-35
   PubMed Web of Science ®Google Scholar
• Requena-Méndez A, Goñi P, Lóbez S, et al. A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India. Clin Microbiol Infect 2014;20:o135-8
   PubMed Web of Science ®Google Scholar
• Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001;14:150-64
   PubMed Web of Science ®Google Scholar
• Upcroft JA, Upcroft P. Drug resistance and Giardia. Parasitol Today 1993;9:187-90
   PubMedGoogle Scholar
• Upcroft P. Drug resistance in Giardia: clinical versus laboratory isolates. Drug Resist Updates 1998;1:166-8
   PubMed Web of Science ®Google Scholar
• Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf 2003;2:529-41
   PubMedGoogle Scholar
• Upcroft JA, Campbell RW, Upcroft P. Quinacrine-resistant Giardia duodenalis. Parasitology 1996;112:309-13
   PubMed Web of Science ®Google Scholar
• Linquist HD. Induction of albendazole resistance in Giardia lamblia. Microb Drug Resist 1996;2:433-4
   PubMed Web of Science ®Google Scholar
• Wolfe MS. Giardiasis. Clin Microbiol Rev 1992;5:93-100
   PubMed Web of Science ®Google Scholar
• Bernal-Redondo R, Martinez-Mendez LG, Mendoza-Chavez A, et al. Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts. J Submicrosc Cytol Pathol 2004;36:241-5
   PubMedGoogle Scholar
• Gillin FD, Diamond LS. Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. J Antimicrob Chemother 1981;8:305-16
   PubMed Web of Science ®Google Scholar
• Genel F, Erermis S, Aksu G, et al. Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis. Hum Psychopharmacol 2002;17:357-9
   PubMed Web of Science ®Google Scholar
• Smith PD, Gillin FD, Spira WM, Nash TE. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response. Gastroenterology 1982;83:797-803
   PubMed Web of Science ®Google Scholar
• Crouch AA, Seow WK, Whitman LM, Thong YH. Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone. Trans R Soc Trop Med Hyg 1990;84:246-8
   PubMed Web of Science ®Google Scholar
• Popović OS, Milović V. Propranolol and metronidazole for the treatment of metronidazole-resistant giardiasis. J Clin Gastroenterol 1990;12:604-5
   PubMed Web of Science ®Google Scholar
• Andrews B J, Panitescu D, Jipa GH, et al. Chemotherapy for giardiasis: randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin. Am J Trop Med Hyg 1995;52:318-21
   PubMed Web of Science ®Google Scholar
• Cacopardo B, Patamia I, Bonaccorso V, et al. Efficacia sinergica dell’associazione albendazole-metronidazolo nella giardiasi refrattaria a monoterapia con metronidazolo. Clin Ter 1995;146:761-7
   PubMedGoogle Scholar
• Pengsaa K, Limkittikul K, Pojjaroen-anant C, et al. Single-dose therapy for giardiasis in school-age children. Southeast Asian J Trop Med Public Health 2002;33:711-17
   PubMedGoogle Scholar
• Pengsaa K, Na-Bangchang K, Limkittikul K, et al. Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis. Ann Trop Med Parasitol 2004;98:349-57
   PubMed Web of Science ®Google Scholar
• Olson ME, Heine J. Synergistic effect of febantel and pyrantel embonate in elimination of Giardia in a gerbil model. Parasitol Res 2009;105(Suppl 1):S135-40
   PubMed Web of Science ®Google Scholar
• Lopez-Velez R, Batlle C, Jiménez C, et al. Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg 2010;83:171-3
   PubMed Web of Science ®Google Scholar
• Hausen MA, Menna-Barreto RF, Lira DC, et al. Synergic effect of metronidazole and pyrantel pamoate on Giardia lamblia. Parasitol Int 2011;60:54-8
   PubMed Web of Science ®Google Scholar
• Upcroft JA, Campbell RW, Benakli K, et al. The efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant anaerobic protozoa. Antimicrob Agents Chemother 1999;43:73-6
   PubMed Web of Science ®Google Scholar
• Escobedo AA, Núñez FA, Moreira I, et al. Chloroquine and albendazole in the treatment of paediatric patients with giardiasis. Ann Trop Med Parasitol 2003;97:367-71
   PubMed Web of Science ®Google Scholar
• Cañete R, Ribas D, Escobedo AA, et al. A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children. West Indian Med J 2010;59:607-11
   PubMed Web of Science ®Google Scholar